HOTH Insider Trading Activity and SEC Form 4 Filings
HOTH insider trading summary
No open-market insider purchases or sales of Hoth Therapeutics, Inc. (HOTH) have been reported on SEC Form 4 in the past 12 months.
Latest HOTH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 16, 2024 | Robb Knie | CEO and President | Buy | $17K (25,000 @ $0.67) |
| Sep 19, 2022 | Robb Knie | CEO and President | Buy | $4K (10,000 @ $0.39) |
| Sep 16, 2022 | Robb Knie | CEO and President | Buy | $4K (10,000 @ $0.40) |
| May 26, 2020 | Anthony Hayes | 10% Owner | Sell | $500K (400,000 @ $1.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.